213 results on '"Aradi, Dániel"'
Search Results
2. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction
3. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
4. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
5. Effect of Intravascular Cooling on Microvascular Obstruction (MVO) in Conscious Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: Results from the COOL AMI EU Pilot Study
6. Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
7. Pharmacology: Inhibitors of P2Y12
8. Comparison of Platelet Function Guided Versus Unguided Treatment With P2Y12 Inhibitors in Patients With Acute Myocardial Infarction (from the Hungarian Myocardial Infarction Registry)
9. Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial
10. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis
11. Gasztroenterológiai-kardiológiai multidiszciplináris konszenzus a hatékony gasztroprotekció szükségességéről antitrombotikus kezelés alkalmazásakor : A Magyar Gasztroenterológiai Társaság és a Magyar Kardiológusok Társaságának közös állásfoglalása
12. Underuse of coronary intervention and its impact on mortality in the elderly with myocardial infarction. A propensity-matched analysis from the Hungarian Myocardial Infarction Registry
13. Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes
14. Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting
15. Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
16. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
17. Cangrelor infusion is associated with an increased risk for bleeding: Meta-analysis of randomized trials
18. A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity
19. Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials
20. Az egyénre szabott vérlemezkegátló-kezelés szerepe PCI után
21. A tromboembóliás események kockázata és megelőzése COVID-19 betegségben
22. Szubokkluzív óriásthrombus a koronáriában: mi lehet a preferált kezelési stratégia?
23. Eptifibatide-induced thrombocytopenia leading to acute stent thrombosis
24. Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort
25. Platelet Function Testing in Patients on Antiplatelet Medications
26. Thrombus aspiration followed by direct stenting: A novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)
27. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
28. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
29. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: Systematic overview and meta-analysis
30. Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention
31. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
32. Improvement in age- and sex-dependent mortality in patients with atrial fibrillation between 2011 and 2016 – a nationwide retrospective study from Hungary
33. New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?—Reply
34. Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome: Systematic Review and Meta-analysis of Randomized Controlled Trials
35. Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity
36. Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial
37. Thienopyridine Therapy Influences Late Outcome After Coronary Stent Implantation
38. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial
39. A 2-es típusú cukorbetegség kardiovaszkuláris megbetegedésre és összmortalitásra kifejtett korfüggő hatása: országos elemzés a NEAK adatbázisa alapján
40. Antithrombotic treatment in patients with atrial fibrillation after stent implantation: is it prime time for the dual strategy in routine practice?
41. Trombocitaaggregáció-gátlás akut koronária szindrómán átesett betegek magas kockázatú alcsoportjaiban
42. Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction
43. Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
44. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
45. Impact of Test Conditions on ADP-Induced Platelet Function Results With the Multiplate Assay: Is Further Standardization Required?
46. Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data
47. Mortality and cancer risk on long-term antiplatelet treatment: What is known and what we still don’t know
48. Assessment of platelet function in patients receiving tirofiban early after primary coronary intervention
49. Impact of CT-apelin and NT-proBNP on identifying non-responders to cardiac resynchronization therapy
50. THE IMPACT OF BLEEDING AND COMORBIDITIES ON THE RISK OF MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.